Facet browsing currently unavailable
Page 1 of 2762 results
Sort by: relevance publication year
Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non–Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure JOURNAL ARTICLE published November 2018 in Clinical Lung Cancer |
Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer JOURNAL ARTICLE published July 2013 in Clinical Lung Cancer |
Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma JOURNAL ARTICLE published January 2022 in Clinical Lung Cancer |
Current Perspectives with Pemetrexed in Thoracic Malignancies JOURNAL ARTICLE published April 2004 in Clinical Lung Cancer |
2003 Highlights From: XII European Cancer Conference Copenhagen, Denmark September 21-25, 2003 JOURNAL ARTICLE published January 2004 in Clinical Lung Cancer |
Tirapazamine with Cisplatin and Vinorelbine in Patients with Advanced Non–Small-Cell Lung Cancer: A Phase I/II Study JOURNAL ARTICLE published April 2005 in Clinical Lung Cancer |
Proportion of Non–Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening JOURNAL ARTICLE published September 2016 in Clinical Lung Cancer |
Outcome Differences Between First- and Second-generation EGFR Inhibitors in Advanced EGFR Mutated NSCLC in a Large Population-based Cohort JOURNAL ARTICLE published September 2019 in Clinical Lung Cancer |
Rapid Clinical and Radiologic Responses With Larotrectinib Treatment in a Patient With TRK-Fusion–Positive Metastatic Lung Cancer JOURNAL ARTICLE published March 2020 in Clinical Lung Cancer |
Long-Term Survival in a Patient with Stage IV Non–Small-Cell Lung Carcinoma After Bone Metastasectomy JOURNAL ARTICLE published May 2005 in Clinical Lung Cancer |
STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non–Small Cell Lung Cancer With No Actionable Gene Alterations JOURNAL ARTICLE published January 2024 in Clinical Lung Cancer |
Phase II Study of Sequential Treatment of Advanced Non–Small-Cell Lung Cancer: Three Cycles of High-Dose Epirubicin Plus Cisplatin Followed by Weekly Vinorelbine JOURNAL ARTICLE published August 2001 in Clinical Lung Cancer |
Southwestern Oncology Group Phase II Trial (S0526) of Pemetrexed in Bronchioloalveolar Carcinoma Subtypes of Advanced Adenocarcinoma JOURNAL ARTICLE published July 2013 in Clinical Lung Cancer |
Editorial Board JOURNAL ARTICLE published November 2018 in Clinical Lung Cancer |
Commentary on “Photodynamic Therapy for Patients with Advanced Non–Small-Cell Carcinoma of the Lung” JOURNAL ARTICLE published August 2001 in Clinical Lung Cancer |
Gemcitabine/Carboplatin in Patients with Metastatic Non–Small-Cell Lung Cancer: Phase II Study of 28-Day and 21-Day Schedules JOURNAL ARTICLE published November 2005 in Clinical Lung Cancer |
Treatment, Rationale, and Study Design of TALISMAN Study: A Randomized Phase II Open-Label Study of Second-line Erlotinib Versus Intermittent Erlotinib Dosing With Docetaxel in the Treatment of Former-Smoker Men Affected by Recurrent Squamous Non–Small-Cell Lung Cancer JOURNAL ARTICLE published January 2011 in Clinical Lung Cancer |
Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations JOURNAL ARTICLE published December 2022 in Clinical Lung Cancer |
A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753) JOURNAL ARTICLE published May 2021 in Clinical Lung Cancer |
Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases JOURNAL ARTICLE published July 2017 in Clinical Lung Cancer |